Saratoga Investment Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Saratoga Investment Corp. on September 16, 2026, with the earliest event reported on that same date. The filing addresses significant changes in the Company's executive leadership structure effective October 31, 2026.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance data.
Material Changes
- Departure of CFO: Henri J. Steenkamp is stepping down as Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary for health-related reasons, effective October 31, 2026.
- Succession Plan:
- Christine Ramdihal (Controller) is promoted to Chief Accounting Officer and Treasurer, becoming the principal financial officer.
- Rochelle Kracoff (Assistant Chief Compliance Officer and Treasury Manager) is promoted to Chief Compliance Officer and Secretary.
- Continuity: Mr. Steenkamp will remain on the Board of Directors and continue as CFO of the Company's small business investment company subsidiaries. He will also provide consulting support during the transition.
Outlook, Risks, and Management Commentary
Management states that Mr. Steenkamp's departure is due to health reasons and that he expressed no disagreement regarding the Company's operations, policies, or practices. The Company emphasizes that the transition plan is designed to ensure continuity and institutional knowledge. No new risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the exact effective date of the leadership transition (October 31, 2026).
- Confirm the new reporting structure for the Chief Accounting Officer and Treasurer roles.
- Review the Company's upcoming quarterly reports to assess the impact of the leadership change on financial operations.
- Check for any subsequent filings regarding the status of Mr. Steenkamp's health or the completion of the transition.